Back
Ascendis Pharma A/S 10K Form
Sell
41
ASND
Ascendis Pharma A/S
Last Price:
$208.60
Seasonality Move:
25.05%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ASND News And Ratings
See the #1 stock for the next 7 days that we like better than ASND
ASND Financial Statistics
Sales & Book Value
| Annual Sales: | $393.3M |
|---|---|
| Cash Flow: | $1.3M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-3.35 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -4.24700 |
|---|---|
| Net Income (TTM): | $-256M |
| Gross Margin: | $333.1M |
| Return on Equity: | -880.05% |
| Return on Assets: | -20.57% |
Ascendis Pharma A/S Earnings Forecast
Key Ascendis Pharma A/S Financial Ratios
-
The Gross Profit Margin over the past 6 years for ASND is 84.69%.
-
The Selling, General & Administrative Expenses for ASND have been equal to 80.06% of Gross Profit Margin.
-
The Research & Development expenses have been 82.38% of Revenue.
-
The Net Earning history of ASND is -103.97% of Total Revenues.
-
Per Share Earnings over the last 13 years have been positive in 5 years.
Ascendis Pharma A/S Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ASND |
| CUSIP: | 04351P |
| Website: | ascendispharma.com |
Debt
| Debt-to-Equity Ratio: | -4.67 |
|---|---|
| Current Ratio: | 1.03 |
| Quick Ratio: | 0.68 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 54.4 |
ASND Technical Analysis vs Fundamental Analysis
Sell
41
Ascendis Pharma A/S (ASND)
is a Sell
Is Ascendis Pharma A/S a Buy or a Sell?
-
Ascendis Pharma A/S stock is rated a SellThe current Ascendis Pharma A/S [ASND] share price is $200.50. The Score for ASND is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.